Camilo J. Llamoza-Torres

Hepatologist and Associate Professor of Medicine at the University Clinical Hospital Virgen de la Arrixaca - University of Murcia. Spain.

[Camilo J. Llamoza-Torres @CamiloJT]

Por qué defiendo los derechos fundamentales? ... Manifiesto por la libertad; en especial de los médicos (y más aún de los médicos extranjeros)... El manantial Juicio https://t.co/JOjdNDoKbn vía @YouTube

[Camilo J. Llamoza-Torres @CamiloJT]

Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis | New England Journal of Medicine https://t.co/PjCeZ26cYg

[Keith Siau @drkeithsiau]

10 commandments for an effective consultation - do you agree with these?

[Keith Siau @drkeithsiau]

“Laser light show” in the colon. What happened here?

[Jordi Bruix @bruixj]

The young investigators of @ILCAnews have launched podcasts of talks with researchers who have run a significant career in liver cancer. Had the honor to run the first one of them and expose my thinking about different aspects @hospitalclinic @idibaps
https://t.co/M92iVhj75d

[Arndt Vogel @ArndtVogel]

Tumour response analyses by RECIST v1.1 and mRECIST in the phase III EMERALD-3 study of tremelimumab plus durvalumab with or without lenvatinib TACE in HCC
@ESMO-GI
👉Primary endpoint met
👉ORR & PFS improved
👉OS benefit for STRIDE
🧐Option to be considered
@myESMO @ASCO @EASLedu @ILCAnews

[Grainne O'Kane @graokane]

🔥RAS inhibition in #PDAC #ESMOGI26
➡️Daraxonrasib as new 2nd line std
1st-line data as mono or in combo GnP
➡️G12Di in combo with chemo
➡️multiple new drugs & some falling off further dvpt
➡️optimal sequences/combos to come
⭐️all patients need access asap!
@myESMO @OncoAlert

[ESMO - Eur. Oncology @myESMO]

📣 Late-Breaking abstracts are now live for the #ESMOGI26 Congress! 1–4 July 2026, Munich, Germany & online. Be among the first to explore the latest advances in GI oncology!
🔗 https://t.co/G9DqvH3zpu
#esmomeetings

[AJG - The American Journal of Gastroenterology @AmJGastro]

The Red Section: Practical Considerations for the Use of Semaglutide in MASH
Matthew A. Odenwald, MD, PhD & Mary E. Rinella, MD, FACG

📕 https://t.co/yxrftuZyn8

[Jordi Bruix @bruixj]

Great review to envision that MASLD may be driven by environmental toxics: the endocrine disruptors and alcohol should not be ignored as main factors for significant steatotic liver disease @EASLnews @JHepatology @ILCAnews
https://t.co/xXBxkD1VoZ

[Camilo J. Llamoza-Torres @CamiloJT]

A Major Step toward a Cure for Hepatitis B Infection | New England Journal of Medicine https://t.co/BPsAxBvtqD

[Camilo J. Llamoza-Torres @CamiloJT]

Bepirovirsen for Chronic Hepatitis B | New England Journal of Medicine https://t.co/Mw0PgENMjO

[Keith Siau @drkeithsiau]

The early bird catches the worm. What is happening here?

[Camilo J. Llamoza-Torres @CamiloJT]

@Brunorm84 @IMIB_RMurcia @FFIS_CARM @UMU Congratulations Bruno and the team!!!

[Bruno Ramos-Molina, PhD @Brunorm84]

Happy to share our latest publication on the hepatoprotective role of BCFAs in lipotoxic PA-induced #MASLD published in Biomedicine & Pharmacotherapy (IF=7.5). Many thanks to all coauthors for their outstanding contributions! @IMIB_RMurcia @FFIS_CARM @UMU https://t.co/nvrn8c9GTt

[Nature Reviews Cancer @NatureRevCancer]

Our JUNE issue is now live!☀️🍉

It features #REVIEWs on:
- Balancing type I interferon signalling
- Interplay between steatotic liver disease and liver cancer
- KMT2C/KMT2D-COMPASS complex loss in cancer
- #ExpertRecommendation on ovarian cancer
📖👇
https://t.co/HlOyH3ml0E

[Human Cell Atlas @humancellatlas]

Remember that Day 3 of the 2026 HCA General Meeting (18 June) will be held at the Broad Institute. Discussions this day will inform and influence the next phase of HCA. Please join us to shape the future!
#HCA2026GM https://t.co/XlUvVdFwPw

[Camilo J. Llamoza-Torres @CamiloJT]

La cirugía robótica, la mejor aliada en la extirpación de tumores https://t.co/vK7u2GMbQ3 vía @libertaddigital

[Keith Siau @drkeithsiau]

Humanoid structures filmed on endoscopy. Can you guess what’s the cause?

[Bruno Ramos-Molina, PhD @Brunorm84]

SUCNR1 coordinates metabolic flux, mitochondrial function, and nutrient-dependent adaptation in hepatocytes @ScienceAdvances https://t.co/g0vvRgsihk

[Keith Siau @drkeithsiau]

Which part of the GI tract is this bleeding from?